Craig Dixon

Craig Dixon is a seasoned professional in the diagnostics and life sciences sector, currently serving as the Partnering & IVD Strategy Lead for Europe at Illumina since December 2021, where leadership involves commercial partnering and market strategy for the European market. Previously, Craig held positions including Director at HistoCyte Laboratories Ltd, focusing on commercialization processes and IVDR preparations, and Senior Manager - Diagnostics at Leica Biosystems, overseeing IVD reagent development and strategy. Craig's earlier experience includes roles as IVD Project Leader at Immunodiagnostic Systems Ltd and various academic positions, culminating in a PhD in Rheumatology/Cell Biology from Newcastle University. Educational credentials also include an HBX Core Program from Harvard Business School Online, along with degrees in Biomedical Sciences and Pharmacology.